Ad is loading...
CWGCX
Price
$67.07
Change
+$0.28 (+0.42%)
Updated
Nov 21 closing price
JGQYX
Price
$16.92
Change
+$0.09 (+0.53%)
Updated
Nov 21 closing price
Ad is loading...

CWGCX vs JGQYX

Header iconCWGCX vs JGQYX Comparison
Open Charts CWGCX vs JGQYXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.07
Change+$0.28 (+0.42%)
VolumeN/A
CapitalizationN/A
Jensen Global Quality Growth Y
Price$16.92
Change+$0.09 (+0.53%)
VolumeN/A
CapitalizationN/A
CWGCX vs JGQYX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. JGQYX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and JGQYX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 126B vs. JGQYX (61.2M). CWGCX pays higher dividends than JGQYX: CWGCX (1.04) vs JGQYX (0.50). CWGCX was incepted earlier than JGQYX: CWGCX (24 years) vs JGQYX (5 years). CWGCX is a more actively managed with annual turnover of: 27.00 vs. JGQYX (16.82). CWGCX has a lower initial minimum investment than JGQYX: CWGCX (250) vs JGQYX (1000000). CWGCX annual gain was more profitable for investors over the last year : 17.95 vs. JGQYX (13.51).
CWGCXJGQYXCWGCX / JGQYX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years5 years-
Gain YTD13.58410.269132%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets126B61.2M205,882%
Annual Yield % from dividends1.040.50209%
Returns for 1 year17.9513.51133%
Returns for 3 years4.559.5148%
Returns for 5 years37.99N/A-
Returns for 10 years46.44N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRA27.440.61
+2.27%
Coterra Energy
USNA39.36-0.16
-0.40%
USANA Health Sciences
RDNT81.30-0.86
-1.05%
RadNet
AXDX1.67-0.03
-1.76%
Accelerate Diagnostics
TCRX3.94-0.18
-4.37%
TScan Therapeutics